PNC Financial Services Group
GBT

PNC Financial Services Group’s Global Blood Therapeutics, Inc. GBT Stock Holding History

PNC Financial Services Group’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-5
Closed – – 4928
2022
Q3 		$0 Sell
5
-1,405
-100% -$77.5K ﹤0.01% 4703
2022
Q2 		$44K Sell
1,410
-518
-27% -$15.2K ﹤0.01% 3069
2022
Q1 		$66K Sell
1,928
-1,985
-51% -$59.3K ﹤0.01% 2957
2021
Q4 		$114K Sell
3,913
-447
-10% -$13.8K ﹤0.01% 2600
2021
Q3 		$111K Buy
4,360
+638
+17% +$18.8K ﹤0.01% 2585
2021
Q2 		$131K Sell
3,722
-454
-11% -$17.7K ﹤0.01% 2497
2021
Q1 		$170K Sell
4,176
-46
-1% -$2.11K ﹤0.01% 2268
2020
Q4 		$183K Sell
4,222
-2,330
-36% -$115K ﹤0.01% 2124
2020
Q3 		$362K Sell
6,552
-23
-0.3% -$1.46K ﹤0.01% 1556
2020
Q2 		$414K Buy
6,575
+693
+12% +$47.5K ﹤0.01% 1495
2020
Q1 		$300K Buy
5,882
+1,530
+35% +$102K ﹤0.01% 1578
2019
Q4 		$346K Sell
4,352
-454
-9% -$26.9K ﹤0.01% 1715
2019
Q3 		$233K Buy
4,806
+454
+10% +$23.7K ﹤0.01% 2051
2019
Q2 		$229K Hold
4,352
– – ﹤0.01% 2085
2019
Q1 		$230K Hold
4,352
– – ﹤0.01% 2065
2018
Q4 		$179K Sell
4,352
-1
-0% -$37 ﹤0.01% 2125
2018
Q3 		$165K Buy
4,353
+3,835
+740% +$170K ﹤0.01% 2294
2018
Q2 		$23K Buy
518
+202
+64% +$9.2K ﹤0.01% 3400
2018
Q1 		$15K Buy
316
+290
+1,115% +$16.2K ﹤0.01% 3562
2017
Q4 		$1K Buy
+26
New +$971 ﹤0.01% 4113

Other funds holding GBT

BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

PNC Financial Services Group's GBT Position: Q4 2022 in Review

PNC Financial Services Group sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 5 shares.

PNC Financial Services Group first reported a position in GBT in Q4 2017 and held it in 20 quarters. The position peaked at $414K in Q2 2020. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

  • PNC Financial Services Group reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
  • PNC Financial Services Group sold 5 Global Blood Therapeutics, Inc. shares in Q4 2022.
  • PNC Financial Services Group first reported a position in Global Blood Therapeutics, Inc. in Q4 2017 and held it in 20 quarters.
  • PNC Financial Services Group's Global Blood Therapeutics, Inc. position peaked at $414K in Q2 2020.
  • 2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on PNC Financial Services Group's 13F filing for Q4 2022, filed 10 Feb 2023.